- Experiment with Sputnik V and Kovishield.
- The Russian director of the Instant Fund says the experiment was a success.
- The report was approved by the Central Government Committee of Experts.
New Delhi: The combination of the Russian Sputnik V vaccine and the Kovshield vaccine from AstraZeneca has been successfully tested. The Russian director of the Instant Fund said that the combined use of vaccines by both companies does not cause side effects.
The Central Government Committee of Experts approved the report that the combined experiment with the Sputnik vaccine and the Kovshield vaccine was a success. The report states that there are no side effects. Kovishield: Experiments with a combination of Sputnik vaccines were carried out in Azerbaijan. The use of a mixture of both vaccines does not cause a decrease in immunity. Russia Direct Investment Fund
The experiment was carried out with 50 people in Azerbaijan. Russia’s Direct Investment Fund said the experiment would help strengthen defense capabilities as new variants of Kovid become widespread in several countries.
Experiments with vaccine additives have been started in several countries in the face of severe cases of Kovid. The Kovishield – Kovaxin combination test will be held at the Medical College, Vellore. The experiment was approved the day before. The expert panel had recommended that Kovid’s vaccines be combined and tested. The directive was issued by the Central Drugs Standard Control Organization (CDSCO).
Niraputhari Puja in Sabarimala on August 16